These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30563687)

  • 1. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.
    Marion O; Lhomme S; Del Bello A; Abravanel F; Esposito L; Hébral AL; Lavayssière L; Cointault O; Ribes D; Izopet J; Kamar N
    J Hepatol; 2019 Jan; 70(1):206-209. PubMed ID: 30563687
    [No Abstract]   [Full Text] [Related]  

  • 2. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.
    Abravanel F; Lhomme S; Rostaing L; Kamar N; Izopet J
    Clin Infect Dis; 2015 Jan; 60(1):96-9. PubMed ID: 25249523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection.
    Marion O; Abravanel F; Izopet J; Kamar N
    Transpl Infect Dis; 2019 Apr; 21(2):e13050. PubMed ID: 30663838
    [No Abstract]   [Full Text] [Related]  

  • 5. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.
    Lhomme S; Kamar N; Nicot F; Ducos J; Bismuth M; Garrigue V; Petitjean-Lecherbonnier J; Ollivier I; Alessandri-Gradt E; Goria O; Barth H; Perrin P; Saune K; Dubois M; Carcenac R; Lefebvre C; Jeanne N; Abravanel F; Izopet J
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1608-14. PubMed ID: 26711757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
    Wang Y; Chen G; Pan Q; Zhao J
    Gastroenterology; 2018 Mar; 154(4):1199-1201. PubMed ID: 29432746
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral therapy in chronic hepatitis E: a systematic review.
    Peters van Ton AM; Gevers TJ; Drenth JP
    J Viral Hepat; 2015 Dec; 22(12):965-73. PubMed ID: 25760481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient.
    Speers DJ; Ma MX; Faddy HM; Nash M; Bowden S; de Boer B; MacNicholas R; MacQuillan G; Adams L
    Med J Aust; 2015 Mar; 202(4):209-11. PubMed ID: 25716605
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin.
    Ambrosioni J; Mamin A; Hadengue A; Bernimoulin M; Samii K; Landelle C; Negro F; Kaiser L
    Clin Microbiol Infect; 2014 Oct; 20(10):O718-20. PubMed ID: 24476456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.
    Kamar N; Lhomme S; Abravanel F; Cointault O; Esposito L; Cardeau-Desangles I; Del Bello A; Dörr G; Lavayssière L; Nogier MB; Guitard J; Ribes D; Goin AL; Broué P; Metsu D; Sauné K; Rostaing L; Izopet J
    Transplantation; 2015 Oct; 99(10):2124-31. PubMed ID: 26214817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.
    van der Valk M; Zaaijer HL; Kater AP; Schinkel J
    J Hepatol; 2017 Jan; 66(1):242-243. PubMed ID: 27702641
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
    Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
    Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Case Genotype 4 Hepatitis E Infection After a Liver Transplant.
    Wu CH; Ho CM; Tsai JH; Sun HY; Hu RH; Lee PH
    Exp Clin Transplant; 2017 Apr; 15(2):228-230. PubMed ID: 26221721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
    Todt D; Meister TL; Steinmann E
    Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin treatment of a patient with chronic hepatitis E. First case reported in Latin America.
    Gruz F; Munné MS; González J; Lizarraga Villagran MA; Raffaele PP; Descalzi VI
    Acta Gastroenterol Latinoam; 2016 Jun; 46(2):122-5. PubMed ID: 28704018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.